Universal Insurance Hldgs (NYSE:UVE) reported quarterly losses of $(1.53) per share which beat the analyst consensus estimate of $(1.61) by 4.97 percent. This is a 82.14 percent decrease over losses of $(0.84) per share
Gainers
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab.